(Q36543120)

14 August 2017

1 reference

title

Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia (English)

1 reference

14 August 2017

2

Steven A Kaplan

1 reference

14 August 2017

Ricardo R Gonzalez

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Expert Opinion on Drug Metabolism & Toxicology

14 August 2017

published in

1 reference

14 August 2017

volume

2

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

609-617

1 reference

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

The worldwide prevalence and epidemiology of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Association of health-related quality of life and benign prostatic enlargement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Endothelin-1 and nitric oxide in the pathogenesis of urinary tract disorders secondary to bladder outlet obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Future drugs for the treatment of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Nitric oxide synthases in normal and benign hyperplastic human prostate: immunohistochemistry and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Mechanisms of endothelial dysfunction in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Nitric oxide control of lower genitourinary tract functions: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Effects of nitric oxide on human and canine prostates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Influence of nitric oxide signalling pathways on pre-contracted human detrusor smooth muscle in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Biological correlates of p27 compartmental expression in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Review of tadalafil in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

IC351 (tadalafil, Cialis): update on clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2.4.609

21 January 2018

Identifiers

DOI

10.1517/17425255.2.4.609

1 reference

14 August 2017

1 reference